These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 33866336)
1. Role of Can C; Gündoğan C; Yildirim OA; Poyraz K; Güzel Y; Kömek H Hell J Nucl Med; 2021; 24(1):25-35. PubMed ID: 33866336 [TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Correlations between whole body volumetric parameters of Yildirim ÖA; Gündoğan C; Can C; Poyraz K; Erdur E; Kömek H Ann Nucl Med; 2021 May; 35(5):540-548. PubMed ID: 33586097 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting response to second-generation androgen receptor axis-targeted therapy, and the prognosis in metastatic hormone-refractory prostate cancer patients. Oruç Z; Güzel Y; Ebinç S; Kömek H; Küçüköner M; Kaplan MA; Oruç İ; Urakçi Z; Işikdoğan A Nucl Med Commun; 2021 Dec; 42(12):1336-1346. PubMed ID: 34366407 [TBL] [Abstract][Full Text] [Related]
5. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients. Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731 [TBL] [Abstract][Full Text] [Related]
6. Schmidkonz C; Cordes M; Schmidt D; Bäuerle T; Goetz TI; Beck M; Prante O; Cavallaro A; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1862-1872. PubMed ID: 29725716 [TBL] [Abstract][Full Text] [Related]
7. Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective-Prospective [ Kluge K; Einspieler H; Haberl D; Spielvogel C; Stoiber S; Vraka C; Papp L; Wunsch S; Egger G; Kramer G; Grubmüller B; Shariat S; Hacker M; Kenner L; Haug A J Nucl Med; 2024 Jan; 65(1):63-70. PubMed ID: 38050125 [TBL] [Abstract][Full Text] [Related]
8. Can the Gleason score be predicted in patients with prostate cancer? A dynamic contrast-enhanced MRI, Akkaya H; Dilek O; Özdemir S; Taş ZA; Öztürk İS; Gülek B Diagn Interv Radiol; 2023 Sep; 29(5):647-655. PubMed ID: 37395389 [TBL] [Abstract][Full Text] [Related]
10. Assessment of the role of Ga-68 PSMA I&T PET/CT in response evaluation to docetaxel therapy in castration resistant prostate cancer patients. Özülker T; Özülker F Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):292-298. PubMed ID: 32595026 [TBL] [Abstract][Full Text] [Related]
12. A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [ Lv J; Yu H; Yin H; Shi Y; Shi H Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):919-927. PubMed ID: 37940684 [TBL] [Abstract][Full Text] [Related]
13. Comparison of discovery rates and prognostic utility of [ Kluge K; Einspieler H; Haberl D; Spielvogel C; Amereller D; Egger G; Kramer G; Grubmüller B; Shariat S; Hacker M; Kenner L; Haug A Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2833-2842. PubMed ID: 38693454 [TBL] [Abstract][Full Text] [Related]
14. Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT. Caglar M; Tuncel M; Yildiz E; Karabulut E Ann Nucl Med; 2020 Dec; 34(12):932-941. PubMed ID: 32975741 [TBL] [Abstract][Full Text] [Related]
15. Initial Experience with Volumetric Schmuck S; von Klot CA; Henkenberens C; Sohns JM; Christiansen H; Wester HJ; Ross TL; Bengel FM; Derlin T J Nucl Med; 2017 Dec; 58(12):1962-1968. PubMed ID: 28522740 [TBL] [Abstract][Full Text] [Related]
16. von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806 [TBL] [Abstract][Full Text] [Related]
17. Intraindividual comparison between Spohn S; Jaegle C; Fassbender TF; Sprave T; Gkika E; Nicolay NH; Bock M; Ruf J; Benndorf M; Gratzke C; Grosu AL; Zamboglou C Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2796-2803. PubMed ID: 32342192 [TBL] [Abstract][Full Text] [Related]
18. Correlations of Topuz ÖV; Aksu A; Erinç SR; Tamam MÖ Hell J Nucl Med; 2021; 24(1):60-65. PubMed ID: 33866340 [TBL] [Abstract][Full Text] [Related]
19. Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses. Aksu A; Vural Topuz Ö; Yılmaz G; Çapa Kaya G; Yılmaz B Ann Nucl Med; 2022 Mar; 36(3):310-318. PubMed ID: 34988888 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance and Clinical Impact of Cerci JJ; Fanti S; Lobato EE; Kunikowska J; Alonso O; Medina S; Novruzov F; Lengana T; Granados C; Kumar R; Rangarajan V; Al-Ibraheem A; Hourani M; Ali NS; Ahmad A; Keidar Z; Küçük O; Elboga U; Bogoni M; Paez D J Nucl Med; 2022 Feb; 63(2):240-247. PubMed ID: 34215674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]